EudraCT Number: 2017-003643-38 Sponsor Protocol Number: 17-HPNCL-01 Start Date:
Sponsor Name: Fondation Lenval - Hôpitaux Pédiatriques de Nice CHU-LENVAL
Full Title: INTRANASAL KETAMINE IN THE REDUCTION OF THE ISOLATED FRACTURES OF THE HIGHER MEMBER OF THE CHILD TO PEDIATRIC EMERGENCIES
Medical condition: a fracture isolated from the distal end of the closed upper limb, requiring a reduction
Disease: Version SOC Term Classification Code Term Level
20.0 10022117 - Injury, poisoning and procedural complications 10016997 Forearm fracture PT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2017-004207-52 Sponsor Protocol Number: CQGE031C2202 Start Date:
Sponsor Name: Novartis Pharma AG
Full Title: A multicenter, randomized, double-blind, placebo-controlled phase 2b dose-finding study to investigate the efficacy and safety of ligelizumab (QGE031) in adolescent patients with Chronic Spontaneou...
Medical condition: Chronic Spontaneous Urticaria
Disease: Version SOC Term Classification Code Term Level
20.0 10040785 - Skin and subcutaneous tissue disorders 10072757 Chronic spontaneous urticaria PT
Population Age: Adolescents, Under 18 Gender: Male, Female
Trial protocol: DE (Completed) ES (Completed) BE (Completed) HU (Completed) EE (Completed)
Trial results: View results
EudraCT Number: 2014-000791-26 Sponsor Protocol Number: PHRI13-GF/LEVNEONAT-1 Start Date:
Sponsor Name: CHRU TOURS
Full Title: Lévétiracétam pour le traitement en première intention des convulsions du nouveau-né : étude de phase II
Medical condition: Nouveau-nés à terme présentant des convulsions dans les premières 72h de vie. Nés dans un contexte d'asphyxie périnatale qu'ils soient éligibles ou non à l'hypothermie thérapeutique.
Disease: Version SOC Term Classification Code Term Level
19.0 100000004852 10070512 Hypoxic-ischemic encephalopathy LLT
Population Age: Newborns, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2008-007667-17 Sponsor Protocol Number: FINNjA-DM Start Date:
Sponsor Name: Dekan des Fachbereichs Medizin der Johann Wolfgang Goethe-Universität Frankfurt/M.
Full Title: Doppelblinde, randomisierte Placebo-kontrollierte crossover-Studie zur Erfassung des Effektes einer DPP-IV-Hemmung auf die Zahl und Funktion von Progenitorzellen sowie die Endothelfunktion von Pati...
Medical condition: Patients with stable diabetes mellitus typ 2 and HbA1c between 7,0% and 10,0%
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2011-003743-22 Sponsor Protocol Number: D9422C00001 Start Date:
Sponsor Name: AstraZeneca AB
Full Title: A Multicenter, Open label, Non-Comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Medical condition: Crohn's Disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: DE (Completed) IT (Completed)
Trial results: View results

EudraCT Number: 2010-020437-12 Sponsor Protocol Number: DT-DP-D2b Start Date:
Sponsor Name: DermaTools Biotech GmbH
Full Title: A multicentric, double blind, randomized, comparative Phase II b study of the efficacy of a wound healing solution in patients with diabetic foot ulcer
Medical condition: diabetic foot ulcer
Disease: Version SOC Term Classification Code Term Level
12.1 10012664 Diabetic foot ulcer LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended) LV (Prematurely Ended) LT (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2016-001478-14 Sponsor Protocol Number: 071301 Start Date:
Sponsor Name: Baxalta Innovations GmbH
Full Title: A PROSPECTIVE, PHASE 3, OPEN LABEL, INTERNATIONAL MULTICENTER STUDY ON EFFICACY AND SAFETY OF PROPHYLAXIS WITH rVWF IN SEVERE VON WILLEBRAND DISEASE
Medical condition: Hereditary severe von Willebrand Disease
Disease: Version SOC Term Classification Code Term Level
19.0 10010331 - Congenital, familial and genetic disorders 10047715 Von Willebrand's disease PT
19.0 10010331 - Congenital, familial and genetic disorders 10055168 Von Willebrand's factor deficiency LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) IT (Completed) CZ (Completed) NL (Completed) ES (Completed) DE (Completed) FI (Completed) FR (Completed)
Trial results: View results

EudraCT Number: 2017-001376-28 Sponsor Protocol Number: NL57885.091.16 Start Date:
Sponsor Name: Radboud University Medical Center
Full Title: Multi-center, randomized non-inferiority trial of early treatment versus expectative management of patent ductus arteriosus in preterm infants.
Medical condition: Patent ductus arteriosus in the preterm infant
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
Trial protocol: NL (Ongoing) BE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2021-000492-36 Sponsor Protocol Number: HOPECOVID-19 Start Date:
Sponsor Name: UCLouvain
Full Title: Home and Outpatients Precocious Eradication of COVID-19
Medical condition: COVID-19
Disease: Version SOC Term Classification Code Term Level
23.0 100000004862 10084382 Coronavirus disease 2019 LLT
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: BE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2012-002606-40 Sponsor Protocol Number: CLCZ696B2207 Start Date:
Sponsor Name: Novartis Pharma Service AG
Full Title: A randomized, double-blind, parallel group study to evaluate metabolic effects of LCZ696 and amlodipine in obese hypertensive subjects
Medical condition: Mild to moderate essential hypertension in obese subjects
Disease: Version SOC Term Classification Code Term Level
14.1 10047065 - Vascular disorders 10020772 Hypertension PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) NL (Completed)
Trial results: View results